Additive value of adult bone-marrow-derived cell transplantation to conventional revascularization in chronic ischemic heart disease: a systemic review and meta-analysis

Bibliography

• Burchfield JS, Iwasaki M, Koyanagi M, Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ Res 2008;11:203-11
   Google Scholar
• Li Y, Hiroi Y, Ngoy S, Notch1 in bone marrow-derived cells mediates cardiac repair after myocardial infarction. Circulation 2011;123:866-76
   PubMed Web of Science ®Google Scholar
• Murry CE, Soonpaa MH, Reinecke H, Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8
   PubMed Web of Science ®Google Scholar
• Hatzistergos KE, Quevedo H, Oskouei BN, Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010;107:913-22
   PubMed Web of Science ®Google Scholar
• Assmus B, Rolf A, Erbs S, Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 2010;3:89-96
   PubMedGoogle Scholar
• Meyer GP, Wollert KC, Lotz J, Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 2009;30(24):2978-84
   PubMed Web of Science ®Google Scholar
• Martin-Rendon E, Brunskill SJ, Hyde CJ, Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008;29:1807-18
   PubMed Web of Science ®Google Scholar
• Zhang S, Sun A, Xu D, Impact of timing on efficacy and safety of intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials. Clin Cardiol 2009;32:458-66
   PubMed Web of Science ®Google Scholar
• van Ramshorst J, Bax JJ, Beeres SL, Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 2009;301:1997-2004
   PubMed Web of Science ®Google Scholar
• Losordo DW, Schatz RA, White CJ, Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a Phase I/IIa double-blind, randomized controlled trial. Circulation 2007;115:3165-72
   PubMed Web of Science ®Google Scholar
• Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323:42-6
   PubMed Web of Science ®Google Scholar
• Chen S, Liu Z, Tian N, Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. J Invasive Cardiol 2006;18:552-6
   PubMedGoogle Scholar
• Assmus B, Honold J, Schachinger V, Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-32
   PubMed Web of Science ®Google Scholar
• Erbs S, Linke A, Adams V, Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 2005;97:756-62
   PubMed Web of Science ®Google Scholar
• Hendrikx M, Hensen K, Clijsters C, Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006;114:I101-7
   Web of Science ®Google Scholar
• Kang HJ, Lee HY, Na SH, Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 2006;114:I145-51
   PubMed Web of Science ®Google Scholar
• Patel AN, Geffner L, Vina RF, Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 2005;130:1631-8
   PubMed Web of Science ®Google Scholar
• Yao K, Huang R, Qian J, Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function. Heart 2008;94:1147-53
   PubMed Web of Science ®Google Scholar
• Zhao Q, Sun Y, Xia L, Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. Ann Thorac Surg 2008;86:1833-40
   PubMed Web of Science ®Google Scholar
• Stamm C, Kleine HD, Choi YH, Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007;133:717-25
   PubMed Web of Science ®Google Scholar
• Ang KL, Chin D, Leyva F, Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nat Clin Pract Cardiovasc Med 2008;5:663-70
   PubMedGoogle Scholar
• Kang S, Yang YJ, Li CJ, Gao RL. Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis 2008;19:327-35
   PubMed Web of Science ®Google Scholar
• Tayyareci Y, Sezer M, Umman B, Intracoronary autologous bone marrow-derived mononuclear cell transplantation improves coronary collateral vessel formation and recruitment capacity in patients with ischemic cardiomyopathy: a combined hemodynamic and scintigraphic approach. Angiology 2008;59:145-55
   PubMed Web of Science ®Google Scholar
• Driesen RB, Verheyen FK, Dijkstra P, Structural remodelling of cardiomyocytes in the border zone of infarcted rabbit heart. Mol Cell Biochem 2007;302:225-32
   PubMed Web of Science ®Google Scholar
• Li SH, Lai TY, Sun Z, Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery. J Thorac Cardiovasc Surg 2009;137:1225-33; e1221
   PubMed Web of Science ®Google Scholar
• Suzuki K, Brand NJ, Smolenski RT, Development of a novel method for cell transplantation through the coronary artery. Circulation 2000;102(19 Suppl 3):III359-64
   Google Scholar
• Ciulla MM, Ferrero S, Gianelli U, Direct visualization of neo-vessel formation following peripheral injection of bone marrow derived CD34+ cells in experimental myocardial damage. Micron 2007;38:321-2
   PubMed Web of Science ®Google Scholar
• Agbulut O, Vandervelde S, Al Attar N, Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 2004;44:458-63
   PubMed Web of Science ®Google Scholar
• Valgimigli M, Rigolin GM, Fucili A, CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 2004;110:1209-12
   PubMed Web of Science ®Google Scholar
• Brunskill SJ, Hyde CJ, Doree CJ, Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease. Eur J Heart Fail 2009;11:887-96
   PubMed Web of Science ®Google Scholar
• Seeger FH, Tonn T, Krzossok N, Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 2007;28:766-72
   PubMed Web of Science ®Google Scholar